Cardiovascular Diseases Clinical Trial
Official title:
Pilot Medical Evaluation of the T50 Calcification Inhibition Test in NephroCare Clinics
Verified date | February 2022 |
Source | Fresenius Medical Care Deutschland GmbH |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This pilot study aims to evaluate in an exploratory way the predictive power of a novel in vitro test (T50 Calcification Inhibition Test, T50 CIT), which measures the mineralization inhibition capacity of blood, in terms of its association with time to all-cause mortality in haemodialysis patients.
Status | Completed |
Enrollment | 776 |
Est. completion date | March 4, 2020 |
Est. primary completion date | October 5, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Informed consent signed and dated by study patient and investigator/authorised physician - Minimum age of 18 years - Incident and prevalent haemodialysis patients - Three haemodialysis treatments per week Exclusion Criteria: - Any condition which could interfere with the patient's ability to comply with the study - Pregnancy (pregnancy test will be conducted with female patients aged <= 55 years) or lactation period - Participation in an interventional clinical study during the preceding 30 days |
Country | Name | City | State |
---|---|---|---|
Spain | Centro de Diálisis Barcelona - Diagonal | Barcelona | |
Spain | Centro de Diálisis Barcelona - Glories | Barcelona | |
Spain | Centro de Diálisis Barcelona - Rosselló | Barcelona | |
Spain | Centro de Diálisis Granollers | Granollers | |
Spain | Centro de Diálisis Hospitalet | L'Hospitalet De Llobregat | |
Spain | Centro de Diálisis Reus | Reus | |
Spain | Centro de Diálisis Tarragona | Tarragona | |
Spain | Centro de Diálisis Terrassa | Terrassa |
Lead Sponsor | Collaborator |
---|---|
Fresenius Medical Care Deutschland GmbH |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | T50 CIT values | The primary objective of this pilot study is to exploratory examine the predictive power of baseline T50 CIT values in terms of their association with time to all-cause mortality in haemodialysis patients. | Baseline after signed informed consent |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|